0000000000482510

AUTHOR

Antonio Pérez-martínez

showing 6 related works from this author

Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy

2021

Abstract COVID‐19 disease is the manifestation of syndrome coronavirus 2 (SARS‐CoV‐2) infection, which is causing a worldwide pandemic. This disease can lead to multiple and different symptoms, being lymphopenia associated with severity one of the most persistent. Natural killer cells (NK cells) are part of the innate immune system, being fighting against virus‐infected cells one of their key roles. In this study, we determined the phenotype of NK cells after COVID‐19 and the main characteristic of SARS‐CoV‐2‐specific‐like NK population in the blood of convalescent donors. CD57+ NKG2C+ phenotype in SARS‐CoV‐2 convalescent donors indicates the presence of ‘memory’/activated NK cells as it ha…

DrugAdultMaleCèl·lulesmedia_common.quotation_subjectImmunologyPopulationBlood DonorsDiseaseHuman leukocyte antigenNK cellsmedicine.disease_causeCell therapyCOVID‐19medicineImmunology and AllergyHumanseducationmedia_commonCoronaviruseducation.field_of_studyInnate immune systembusiness.industrySARS-CoV-2fungiCOVID-19ConvalescenceOriginal ArticlesMiddle AgedPhenotypeAdoptive TransferKIRHLAKiller Cells NaturalImmunologyOriginal ArticleFemalecell therapybusinessImmunologic MemoryImmunology
researchProduct

A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in C…

2021

Abstract Background: Adoptive cell immunotherapies for opportunistic virus in immunocompromised patients using haploidentical memory T cells have shown to be safe and effective. Since severe cases of COVID-19 present a dysregulated immune system with T cell lymphopenia and a hyper-inflammatory state we have proposed that a similar strategy could be proven to be efficient for COVID-19 patients. This is a study protocol of an open-label, multicenter, double-arm, randomized, dose-finding phase I/II clinical trial to evaluate the feasibility, safety, tolerability, and efficacy of the administration of a single dose of allogenic SARS-CoV-2 specific memory CD45RA - T cells and Natural Killer (NK)…

704.Cellular Immunotherapies: Clinicalbusiness.industryImmunologyCell BiologyHematologymedicine.disease_causemedicine.diseaseBiochemistryPneumoniaPhase i iiMulti center studyImmunologymedicineDose escalationbusinessCoronavirusBlood
researchProduct

Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform

2018

Research is the cornerstone of medical progress. Paediatric research has its own nuances and represents an additional challenge due to the intrinsic characteristics of the paediatric population compared with adults. Despite the tremendous importance of childhood health and its impact during adulthood, society is still not convinced about the importance of conducting research in paediatrics. This also applies to paediatricians themselves, who think about research as a discipline that does not directly involve them.The Spanish Academy of Paediatrics has developed a specific research platform- INVEST-AEP- to try to help and answer the challenges associated with paediatric research in the socie…

Medical educationBiomedical ResearchPediatríaCornerstoneFormaciónPediatricsRJ1-57003 medical and health sciences0302 clinical medicineIncentiveWork (electrical)Spain030225 pediatrics030220 oncology & carcinogenesisManagement of Technology and InnovationPolitical scienceInvestigaciónRedesDay to dayPaediatric populationAnales de Pediatría (English Edition)
researchProduct

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

2021

Abstract Background Effective treatments are still needed to reduce the severity of symptoms, time of hospitalization, and mortality of COVID-19. SARS-CoV-2 specific memory T-lymphocytes obtained from convalescent donors recovered can be used as passive cell immunotherapy. Methods Between September and November 2020 a phase 1, dose-escalation, single centre clinical trial was conducted to evaluate the safety and feasibility of the infusion of CD45RA− memory T cells containing SARS-CoV-2 specific T cells as adoptive cell therapy against moderate/severe cases of COVID-19. Nine participants with pneumonia and/or lymphopenia and with at least one human leukocyte antigen (HLA) match with the don…

Medicine (General)medicine.medical_specialtybusiness.industrymedicine.medical_treatmentLymphocyteMicrochimerismGeneral MedicineImmunotherapyEarly warning scoreCell therapyClinical trialR5-920Clinical researchmedicine.anatomical_structureInternal medicinemedicinebusinessAdverse effectResearch PaperEClinicalMedicine
researchProduct

Paediatric research in Spain: Challenges and priorities. INVEST-AEP Platform

2018

La investigación clínica es la piedra angular para el desarrollo de la Medicina, y, en el ámbito de la Pediatría, supone un reto adicional debido a las peculiaridades que diferencian a los niños de los adultos. A pesar del enorme impacto de la salud infantil en el resto de la vida, nuestra sociedad aún no está suficientemente concienciada sobre la importancia de la investigación pediátrica, que, en general, se encuentra también muy alejada del día a día de quienes nos dedicamos a esta profesión. Desde la Asociación Española de Pediatría (AEP) se ha creado una plataforma específica de investigación —INVEST-AEP— para dar respuesta específica a los retos de la investigación en el seno de nuest…

MedicamentoResearchPediatríaInvestigación médicaCornerstonePaediatricsNetworkPediatricsRJ1-57003 medical and health sciences0302 clinical medicineIncentiveNursing030225 pediatricsPolitical sciencePediatrics Perinatology and Child HealthTraining030212 general & internal medicineDay to dayPaediatric population
researchProduct

Effects of Exercise on the Immune Function of Pediatric Patients With Solid Tumors

2017

The purpose of this study was to assess the effects of an in-hospital exercise intervention during neoadjuvant chemotherapy on the inflammatory profile and immune cell subpopulation in 20 children with solid tumors (control [n = 11] and exercise group [n = 9]). Although no significant interaction (group × time) effect was found with an analysis of variance test, we found a trend toward an interaction effect for natural killer cells expressing the immunoglobulin-like receptor KIR2DS4, with their numbers remaining stable in the exercise group but increasing in controls. Our data support that exercise interventions are safe in pediatric cancer patients with solid tumors during chemotherapy tre…

MaleOncologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentPhysical fitnessPhysical Therapy Sports Therapy and RehabilitationBody Mass Indexlaw.invention03 medical and health sciences0302 clinical medicineImmune systemRandomized controlled triallawNeoplasmsInternal medicinemedicineHumansMuscle StrengthExercise physiologyChildEducación físicaExerciseChemotherapybusiness.industryRehabilitationCancerResistance Training030229 sport sciencesCáncermedicine.diseasePediatric cancerNeoadjuvant TherapyExercise TherapyKiller Cells NaturalTreatment OutcomeChemotherapy AdjuvantPhysical Fitness030220 oncology & carcinogenesisImmunologyQuality of LifeFemalebusinessKIR2DS4American Journal of Physical Medicine & Rehabilitation
researchProduct